Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
Luo Y, Gadd ME, Qie Y, Otamendi-Lopez A, Sanchez-Garavito JE, Brooks MM, Ulloa Navas MJ, Hundal T, Li S, Jones VK, Lou Y, Patel T, Dronca R, Kharfan-Dabaja MA, Dong H, Quinones-Hinojosa A, Qin H.
Luo Y, et al. Among authors: jones vk.
Mol Ther Oncol. 2024 Oct 5;32(4):200891. doi: 10.1016/j.omton.2024.200891. eCollection 2024 Dec 19.
Mol Ther Oncol. 2024.
PMID: 39498357
Free PMC article.